Richardson J Craig, Bowtell Richard W, Mäder Karsten, Melia Colin D
Formulation Insights, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1191-209. doi: 10.1016/j.addr.2005.01.024. Epub 2005 Apr 14.
Magnetic resonance imaging (MRI) is a powerful imaging modality that provides internal images of materials and living organisms on a microscopic and macroscopic scale. It is non-invasive and non-destructive, and one of very few techniques that can observe internal events inside undisturbed specimens in situ. It is versatile, as a wide range of NMR modalities can be accessed, and 2D and 3D imaging can be undertaken. Despite widespread use and major advances in clinical MRI, it has seen limited application in the pharmaceutical sciences. In vitro studies have focussed on drug release mechanisms in polymeric delivery systems, but isolated studies of bioadhesion, tablet properties, and extrusion and mixing processes illustrate the wider potential. Perhaps the greatest potential however, lies in investigations of pharmaceuticals in vivo, where pilot human and animal studies have demonstrated we can obtain unique insights into the behaviour of gastrointestinal, topical, colloidal, and targeted drug delivery systems.
磁共振成像(MRI)是一种强大的成像方式,可在微观和宏观尺度上提供材料和生物体的内部图像。它是非侵入性和非破坏性的,是极少数能够原位观察未受干扰标本内部情况的技术之一。它具有通用性,因为可以采用多种核磁共振方式,并且能够进行二维和三维成像。尽管临床MRI已得到广泛应用并取得了重大进展,但它在制药科学中的应用仍然有限。体外研究主要集中在聚合物给药系统中的药物释放机制,但关于生物黏附、片剂性质以及挤出和混合过程的个别研究表明了其更广泛的潜力。然而,最大的潜力可能在于体内药物研究,在这方面,初步的人体和动物研究表明,我们能够获得关于胃肠道、局部、胶体和靶向给药系统行为的独特见解。